title: Clinical outcomes after implantation of small diameter (=2.5 mm) sirolimus- versus paclitaxel-eluting stents.
authors.forename: Laurent
authors.initials: L
authors.lastname: Bonello
authors.forename: Ashesh N
authors.initials: AN
authors.lastname: Buch
authors.forename: Axel
authors.initials: A
authors.lastname: De Labriolle
authors.forename: Probal
authors.initials: P
authors.lastname: Roy
authors.forename: Daniel H
authors.initials: DH
authors.lastname: Steinberg
authors.forename: Tina L
authors.initials: TL
authors.lastname: Pinto Slottow
authors.forename: Kimberley
authors.initials: K
authors.lastname: Kaneshige
authors.forename: Rebecca
authors.initials: R
authors.lastname: Torguson
authors.forename: William O
authors.initials: WO
authors.lastname: Suddath
authors.forename: Lowell F
authors.initials: LF
authors.lastname: Satler
authors.forename: Kenneth M
authors.initials: KM
authors.lastname: Kent
authors.forename: Augusto D
authors.initials: AD
authors.lastname: Pichard
authors.forename: Ron
authors.initials: R
authors.lastname: Waksman
mesh_terms: D015906:Angioplasty, Balloon, Coronary / Q000295:instrumentation*; D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology; D017023:Coronary Angiography; D054855:Drug-Eluting Stents; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000000981:diagnostic imaging / Q000601:surgery*; D017239:Paclitaxel / Q000494:pharmacology*; D011474:Prosthesis Design; D012189:Retrospective Studies; D020123:Sirolimus / Q000494:pharmacology*; D016896:Treatment Outcome
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D007166:Immunosuppressive Agents; D017239:Paclitaxel; D020123:Sirolimus